XML 85 R75.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE-BASED PAYMENTS (Q2) (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
SHARE-BASED PAYMENTS    
Schedule of movements in share awards
 
 ​ ​
Period ended June 30, 2022
 
 ​ ​
Number of options
(’000)
 ​ ​
Average exercise
price per share
award (US$)
 ​ ​
Average fair value
per share award
(US$)
As at January 1, 2022
 ​ ​
9,419
 ​ ​
3.50
 ​ ​
26.16
Granted during the period
 ​ ​
1,059
 ​ ​
3.50
 ​ ​
19.77
Forfeited
​ ​
(125)
 ​ ​
3.50
 ​ ​
25.73
As at June 30, 2022
 ​ ​
10,353
 ​ ​
3.50
 ​ ​
25.52
Vested and exercisable at June 30, 2022
 ​ ​
3,395
 ​ ​
3.50
 ​ ​
25.52

 
 ​ ​
Period ended June 30, 2023
 
 ​ ​
Number of options
(’000)
 ​ ​
Average exercise
price per share
award (US$)
 ​ ​
Average fair value
per share award
(US$)
As at January 1, 2023
 ​ ​
10,398
 ​ ​
3.50
 ​ ​
25.27
Granted during the period
 ​ ​
401
 ​ ​
3.50
 ​ ​
4.72
Forfeited
​ ​
(130)
 ​ ​
3.50
 ​ ​
19.85
As at June 30, 2023
 ​ ​
10,669
 ​ ​
3.50
 ​ ​
24.57
Vested and exercisable at June 30, 2023
 ​ ​
5,293
 ​ ​
3.50
 ​ ​
24.57
 
 ​ ​
Number of
options (’000)
 ​ ​
Average exercise
price per
share option (US$)
 ​ ​
Average
fair value per
share option (US$)
As at January 1, 2021
 ​ ​
—
 ​ ​
—
 ​ ​
—
Granted during the year
 ​ ​
1,097,852
 ​ ​
0.03
 ​ ​
0.23
As at December 31, 2021
 ​ ​
1,097,852
 ​ ​
0.03
 ​ ​
0.23
 
 ​ ​
Number of
options (’000)
 ​ ​
Average exercise
price per
share option (US$)
 ​ ​
Average
fair value per
share option (US$)
Granted during the year
 ​ ​
139,690
 ​ ​
0.03
 ​ ​
0.16
Forfeited
 ​ ​
(25,597)
 ​ ​
0.03
 ​ ​
0.22
As at December 31, 2022
 ​ ​
1,211,945
 ​ ​
0.03
 ​ ​
0.22
Vested and exercisable at December 31, 2022
 ​ ​
417,767
 ​ ​
0.03
 ​ ​
0.22
Schedule of share based compensation expense
 
 ​ ​
Period ended June 30,
In thousands of USD
 ​ ​
2022
 ​ ​
2023
Cost of revenue
 ​ ​
5,812
 ​ ​
2,576
General and administrative expenses
 ​ ​
29,256
 ​ ​
11,299
Research and development expenses
 ​ ​
14,906
 ​ ​
6,107
Selling expenses
 ​ ​
4,451
 ​ ​
1,865
Total
 ​ ​
54,425
 ​ ​
21,847
 
 ​ ​
Year ended December 31,
In thousands of USD
 ​ ​
2021
 ​ ​
2022
Cost of revenue
 ​ ​
10,424
 ​ ​
10,050
General and administrative expenses
 ​ ​
54,458
 ​ ​
48,850
Research and development expenses
 ​ ​
18,246
 ​ ​
24,258
Selling expenses
 ​ ​
5,227
 ​ ​
7,490
Total
 ​ ​
88,355
 ​ ​
90,648
Schedule of fair value assumptions of awards
 
 ​ ​
At August 1,
2021
 ​ ​
At November 1,
2021
Dividend yield (%)
 ​ ​
—
 ​ ​
—
Expected volatility (%)
 ​ ​
130.19%
 ​ ​
130.23%
Risk-free interest rate (%)
 ​ ​
1.24%
 ​ ​
1.57%
Exercise multiple
 ​ ​
2.20-2.80
​ ​
2.20

 
 ​ ​
At January 1,
2022
 ​ ​
At April 1,
2022
 ​ ​
At July 1,
2022
 ​ ​
At October 1,
2022
Dividend yield (%)
 ​ ​
—
 ​ ​
—
 ​ ​
—
 ​ ​
—
Expected volatility (%)
 ​ ​
128%
 ​ ​
123%
 ​ ​
120%
 ​ ​
121%
Risk-free interest rate (%)
 ​ ​
1.618%
 ​ ​
2.415%
 ​ ​
2.893%
 ​ ​
3.886%
Exercise multiple
 ​ ​
2.20-2.80
​ ​
2.20
 ​ ​
2.20
 ​ ​
2.20
 
 ​ ​
At January 1,
2023
 ​ ​
At April 1,
2023
Dividend yield (%)
 ​ ​
—
 ​ ​
—
Expected volatility (%)
 ​ ​
121%
 ​ ​
124%
Risk-free interest rate (%)
 ​ ​
4.152%
 ​ ​
4.167%
Exercise multiple
 ​ ​
2.20-2.80
​ ​
2.20
 
 ​ ​
At August 1, 2021
 ​ ​
At November 1, 2021
Dividend yield (%)
 ​ ​
—
 ​ ​
—
Expected volatility (%)
 ​ ​
130.19%
 ​ ​
130.23%
Risk-free interest rate (%)
 ​ ​
1.24%
 ​ ​
1.57%
Exercise multiple
 ​ ​
2.20-2.80
 ​ ​
2.20

 
 ​ ​
At January 1, 2022
 ​ ​
At April 1, 2022
 ​ ​
At July 1, 2022
 ​ ​
At October 1, 2022
Dividend yield (%)
 ​ ​
—
 ​ ​
—
 ​ ​
—
 ​ ​
—
Expected volatility (%)
 ​ ​
128%
 ​ ​
123%
 ​ ​
120%
 ​ ​
121%
Risk-free interest rate (%)
 ​ ​
1.618%
 ​ ​
2.415%
 ​ ​
2.893%
 ​ ​
3.886%
Exercise multiple
 ​ ​
2.20-2.80
 ​ ​
2.20
 ​ ​
2.20
 ​ ​
2.20